🔮 OOTWOracle · All predictions · Odds sheet · Track record · Benchmark

The Psychedelic Approval Odds Sheet

The Oracle's current odds on the 12 nearest-resolving open questions in psychedelic medicine — regenerated daily from live signals. Print it, share it, check back when they resolve.
QuestionOdds
Major news outlet will confuse psilocybin addiction research with recreational microdosing by July 2026
culture · resolves 2026-07-07
48%
A psychedelic stock's big one-day spike likely fades fast
market · resolves 2026-07-08
70%
Media will hype psilocybin cocaine study as 'cure,' then print corrections
culture · resolves 2026-07-12
72%
The dramatic Alzheimer's-psilocybin claim will likely get walked back
culture · resolves 2026-07-15
68%
News outlet will badly distort a psilocybin study finding by August 2026
culture · resolves 2026-07-22
78%
Ibogaine cardiac safety concerns will materially slow or condition U.S. regulatory pathways, requiring mandatory cardiac monitorin
regulation · resolves 2026-07-26
76%
Psilocybin trials will require antidepressant washout by July 2026
research · resolves 2026-07-30
28%
Ibogaine heart risk will force FDA to delay trials into 2027
regulation · resolves 2026-07-31
72%
Major news outlet will expose ibogaine cardiac deaths in veteran programs
culture · resolves 2026-08-01
76%
Federal psychedelic research plan focuses on veterans and avoids MDMA
policy · resolves 2026-08-01
72%
Cardiac screening becomes mandatory in one federal ibogaine bill or guidance
regulation · resolves 2026-08-01
44%
SSRI washout rules mandated across multiple trials by mid-2026
regulation · resolves 2026-08-02
14%
Want the updated sheet every morning?
Daily signal + 5 fresh predictions + the honest track record. Free.
Subscribe free →

Methodology: odds are the Oracle's calibrated confidence, produced by a multi-agent simulation over ~150 daily signals (PubMed, ClinicalTrials.gov, Congress.gov, market data, press). Every question carries a falsifiable resolution rule and is scored publicly — see the track record.